The app and website was publicly released on 2 Apr 2024
Update Jan 2025
The content continues to undergo review by all our cadres.
The content remains subject to the following provisos: - The content will be subject to continuous update and review - Old content (from previous CGOs) will be converted into the new format, using the new tools and layouts - Content may be moved around - The layout will change and reflect the needs of the user - Content will be created - Content may be deleted/retired
CGO development will continue.
Saf [Updated 21 Jan 2025]
Cholecystitis (and biliary tract pathologies)
!Warning
Objectives
To guide the investigation and management of suspected cholecystitis and biliary tract pathologies in the deployed environment.
Scope
This guideline describes the management of patients with suspected cholecystitis and biliary tract pathologies in a forward medical context or deployed Emergency Department.
Definitive diagnosis of severity or complications is unlikely to be available in the deployed setting below Role 2e facilities.
There are separate guidelines for Acute Pancreatitisand Peptic Ulcer Disease (links to follow).
Audience
This guideline is intended for the use of registered healthcare professionals fulfilling a general role in a forward medical location or in an Emergency Department on deployed operations.
Background
Most biliary tract emergency presentations relate to gallstones. Solitary and multiple gallstones of various compositions are common (more than 1 in every 10 adults in the UK has gallstones), with increased risk in those who are overweight, female or aged 40 or over.
Patients may present along a spectrum of illness. Biliary colic pain following food and without features of inflammation may be self-limiting or intermittent. Acute cholecystitis with evidence of inflammation (fever, persistent pain) can become complicated by mucocele, empyema, septic shock and perforation. Stones and bile stasis in the common bile duct can lead to obstructive jaundice, ascending cholangitis, or acute pancreatitis (see separate CGO - link to follow).
Initial Assessment & Management
History: Right hypochondrial or epigastric pain, radiating to the right side and back +/- vomiting. Referred pain may be felt in shoulder tip or interscapular area. May be difficult to differentiate from other causes such as acute pancreatitis and peptic ulcer disease - see separate CGOs. Also consider atypical presentation of acute coronary syndrome (see CGO).
Examination: look for features of acute inflammation – fever, right hypochondrial tenderness (felt particularly on inspiration – Murphy’s sign). A palpable mass may indicate empyema (often high fever, extreme tenderness, septic shock). Charcot’s triad (abdominal pain, jaundice, and fever) implies ascending cholangitis – the patient may be very ill and require fluid resuscitation.
Murphy’s sign is found when palpation in the right upper quadrant on inspiration causes sharp pain that is sufficient to gasp/arrest respiration, but without this finding in the left upper quadrant. Be aware that Murphy's sign is unreliable in older adults and is difficult to elicit in people who are critically ill.
Analgesia: analgesic requirements are likely to be significant in patients with acute cholecystitis, often requiring opioids. Pain should be managed in accordance with individual capabilities. NSAIDS should be avoided.
Anti-emetics: nausea and vomiting are likely to be present. Anti-emetics should be used routinely to reduce these symptoms.
Antibiotics: In the presence of acute inflammation or fever, IV antibiotics should be administered in accordance with deployed antimicrobial guidance for non-traumatic intra-abdominal infection (link to follow).
Oxygen: Pulmonary complications are rare. Utilise supplemental oxygen to aim for SaO2 >92%.
Fluid resuscitation: Hartmanns or other balanced crystalloid are preferred to be used, otherwise saline, with a bolus of 10-20ml/kg if evidence of shock.
Monitoring: monitor urine output and adjust fluid resucitation accordingly, with a target of >0.5ml/kg/hr. In mild cases 4 hourly observations, in moderate or severe hourly observations. 12 lead ECG is advisable as the differential diagnosis for cholecystitis includes inferior myocardial infarction.
Nutrition: eating may exacerbate biliary pain, but there is no need for a patient to be kept formally "nil by mouth" - diet should be allowed as tolerated. Following adequate initial resuscitation, oral fluid intake should be encouraged and intravenous maintenance fluids utilised only if oral intake is inadequate.
Evacuation: Although patients may be able to be temporised in a forward location, evacuation should be considered early as there is significant potential to deteriorate. The management of patients with a prolonged hold is outlined in ‘Prolonged Casualty Care’.
Advanced Assessment & Management
Monitoring goals: urine output of 0.5ml/kg/hr. MAP ≥ 65.
Bloods: VBG, FBC, U&E, LFTs, and Amylase.
Imaging: Trans-abdominal ultrasound is the preferred initial study to detect gallstone disease. If available, CT (contrast-enhanced) scan may be utilised in patients that become systemically unwell, septic or fail to improve.
Nutrition: diet should be encouraged as tolerated, but patients may wish to avoid foods that exacerbate their symptoms (such as fatty foods).
Prolonged Casualty Care
Fluid balance: if evacuation is delayed, continue to encourage oral fluids, supplementing with intravenous fluids only if needed to maintain adequate organ perfusion - target a urine output of >0.5ml/kg/hour either by catheterisation if the patient is unwell or by simply measuring output otherwise.
Analgesia: a regular analgesia plan should be devised. IV preparations should be used unless confident of enteral absorption – gallstone ileus may be present. NSAIDs should be avoided. Regular opioids are likely to be required.
Antibiotics: continue further doses of antibiotics in accordance with deployed antimicrobial guidelines if evacuation is delayed.
Nutrition: patients may trial oral nutrition as pain and nausea allows; those with severe symptoms who are unable to take diet should be encouraged to at least take oral fluids if able.
Prognostication
There is no validated prognostic test or score routinely used in UK-based clinical practice.
Acute cholecystitis may progress to suppurative (abscess), necrotising (partial or full thickness) and perforated cholecystitis. Pericholecystic abscess, fistulae, peritonitis and gallstone ileus are recognised complications.
Acalculous cholecystitis may occur, typically in those who are already critically ill (for example from trauma, severe systemic illness, dehydration, or systemic infections such as malaria) and is associated with higher mortality rates than gallstone-related disease. Antibiotics, supportive management and evacuation to a higher echelon of care are the mainstay.